Keryx to Raise $110 Million Through Issuance of Shares
Keryx Biopharmaceuticals Inc. ( KERX ) announced the pricing of its underwritten public offering of common stock worth $110 million. The company is looking to issue approximately 9.17 million shares of its common stock at a price of $12 per share. […]